Cargando…
Cytokeratin 18 can help predict liver fibrosis in HCV infected patients with type 2 diabetes mellitus
BACKGROUND: To investigate the predictive values of cytokeratin 18 for liver fibrosis in hepatitis C virus (HCV) infected patients with type 2 diabetes mellitus (T2DM). METHODS: 252 HCV-infected patients with T2DM between January 2012 and August 2017 were retrospectively reviewed. Pearson/spearman c...
Autores principales: | Li, Fang, Lei, Feifei, Wen, Chengcai, Ge, Qiu, Zhu, Liyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527716/ https://www.ncbi.nlm.nih.gov/pubmed/34670509 http://dx.doi.org/10.1186/s12876-021-01963-7 |
Ejemplares similares
-
Serum Cytokeratin-18 Levels for Liver Fibrosis Prediction
por: Caviglia, Gian Paolo, et al.
Publicado: (2015) -
Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis
por: Ismail, Saber A, et al.
Publicado: (2017) -
Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis
por: Cha, Seung-Ick, et al.
Publicado: (2012) -
Association of liver biomarkers and cytokeratin-18 in Nonalcoholic fatty liver disease patients
por: Altaf, Benash, et al.
Publicado: (2020) -
The application of cytokeratin-18 as a biomarker for drug-induced liver injury
por: Korver, Samantha, et al.
Publicado: (2021)